SCHEMBL1367944

SCHEMBL1367944

COc1cc(OC)c2cc(C(=O)C=Cc3ccc(Cl)cc3)c(=O)oc2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 11/20 0.71
MAOA P21397 9/20 0.71
ABCG2 Q9UNQ0 5/20 0.61
MAPT P10636 2/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
PLIN1 O60240 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
RAB9A P51151 1/20 0.53
PLIN5 Q00G26 1/20 0.53
KMT2A Q03164 1/20 0.53
ABHD5 Q8WTS1 1/20 0.53
TNFRSF1A P19438 1/20 0.51
HDAC3 O15379 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1368728 1.00 MAOB (0.71) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL1367942 1.00 MAOB (0.71) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL1368389 0.92 MAOB (0.81) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL1368759 0.92 MAOB (0.81) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL1368391 0.92 MAOB (0.81) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL9643053 0.88 MAOB (0.68) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL9643057 0.88 MAOB (0.68) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL1368295 0.87 MAOB (0.62) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL1368070 0.87 MAOB (0.62) MAOBMAOAABCG2MAPTKDM4E
SCHEMBL1368069 0.87 MAOB (0.62) MAOBMAOAABCG2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US claimed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS MAOB 2929/4885MAOA 3570/4885ABCG2 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.